New Jersey Bankruptcy Court

Case number: 2:19-bk-13710 - Immune Pharmaceuticals, Ltd. - New Jersey Bankruptcy Court

Case Information
Case title
Immune Pharmaceuticals, Ltd.
Chapter
7
Judge
Vincent F. Papalia
Filed
02/22/2019
Last Filing
10/22/2024
Asset
Yes
Vol
v
Docket Header

JNTADMN




U.S. Bankruptcy Court
District of New Jersey (Newark)
Bankruptcy Petition #: 19-13710-VFP

Assigned to: Judge Vincent F. Papalia
Chapter 11
Voluntary
Asset


Date filed:  02/22/2019
341 meeting:  04/17/2019
Deadline for filing claims:  07/16/2019

Debtor

Immune Pharmaceuticals, Ltd.

Hillel Street #24
Jerusalem
OUTSIDE U. S.
Israel 94581

represented by
Morris S. Bauer

Norris McLaughlin & Marcus, PA
400 Crossing Boulevard
8th Floor
Bridgewater, NJ 08807
908-252-4345
Email: [email protected]

Catherine L. Corey

Norris McLaughlin, P.A.
400 Crossing Boulevard
Bridgewater, NJ 08807
908-722-4303
Fax : 908-722-0755
Email: [email protected]

Melissa A. Pena

Norris McLaughlin, P.A.
875 Third Avenue
Ste 8th Floor
New York, NY 10022
917-369-8847
Email: [email protected]

U.S. Trustee

U.S. Trustee

US Dept of Justice
Office of the US Trustee
One Newark Center Ste 2100
Newark, NJ 07102
(973) 645-3014
 
 

Latest Dockets
Date Filed#Docket Text
06/05/201931Docket Text
Document re: Notice to Creditors Pursuant to Order Respecting Amendment to Schedules D, E, F, G, H or List of Creditors (related document: 27 Amended Schedules (Fee Attorney) filed by Debtor Immune Pharmaceuticals, Ltd., 29 Order Respecting Amendment to Schedule(s)) filed by Morris S. Bauer on behalf of Immune Pharmaceuticals, Ltd.. (Attachments: # 1 Certificate of Service) (Bauer, Morris) (Entered: 06/05/2019)
06/02/201930Docket Text
BNC Certificate of Notice - Order No. of Notices: 1. Notice Date 06/02/2019. (Admin.) (Entered: 06/03/2019)
05/31/201929Docket Text
Order Respecting Amendment to Schedule(s) E/F (related document: 27 Amended Schedules (Fee Attorney) filed by Debtor Immune Pharmaceuticals, Ltd.). Service of notice of the entry of this order pursuant to Rule 9022 was made on the appropriate parties. See BNC Certificate of Notice. Signed on 5/31/2019. (rh) (Entered: 05/31/2019)
05/31/201928Docket Text
Notice of Failure to File Complete documents filed by the Court. (related document: 27 Amended Schedules (Fee Attorney) filed by Debtor Immune Pharmaceuticals, Ltd.). (rh) (Entered: 05/31/2019)
05/29/2019Docket Text
Receipt of filing fee for Amended Schedules (Fee Attorney)( 19-13710-VFP) [misc,amdsch3a] ( 31.00) Filing Fee. Receipt number A38878587, fee amount $ 31.00. (re: Doc# 27) (U.S. Treasury) (Entered: 05/29/2019)
05/29/201927Docket Text
Amended Schedule(s) : E/F Fee Amount $ 31 filed by Morris S. Bauer on behalf of Immune Pharmaceuticals, Ltd.. (Bauer, Morris) (Entered: 05/29/2019)
04/24/201926Docket Text
Certificate of Service (related document: 24 Order Respecting Amendment to Schedule(s)) filed by Morris S. Bauer on behalf of Immune Pharmaceuticals, Ltd.. (Bauer, Morris) (Entered: 04/24/2019)
04/20/201925Docket Text
BNC Certificate of Notice - Order No. of Notices: 1. Notice Date 04/20/2019. (Admin.) (Entered: 04/21/2019)
04/18/201924Docket Text
Order Respecting Amendment to Schedule(s) E/F (related document: 22 Amended Schedules (Fee Attorney) filed by Debtor Immune Pharmaceuticals, Ltd.). Service of notice of the entry of this order pursuant to Rule 9022 was made on the appropriate parties. See BNC Certificate of Notice. Signed on 4/18/2019. (lc) (Entered: 04/18/2019)
04/17/201923Docket Text
Monthly Operating Report for Filing Period February, 2019 filed by Morris S. Bauer on behalf of Immune Pharmaceuticals, Ltd.. (Bauer, Morris) (Entered: 04/17/2019)